Clinvest Research, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Clinvest Research, LLC - overview
Established
1996
Location
Missouri City, TX, US
Primary Industry
Pharmaceuticals
About
Founded in 1996 by Roger Cady, and based in Texas, US, Clinvest Research, LLC, operates as a pharmaceutical research company that offers medicine and health management through clinical research for chronic conditions such as migraine, arthritis, and diabetes. In May 2022, Headlands Research, a portfolio company of KKR, acquired Clinvest Research, LLC. As of 2023, the company had conducted over 600 clinical trials for various pharmaceutical companies. Clinvest Research offers various pharmaceutical research services that include conducting FDA Phase II-IV research in areas including headache, hypertension, diabetes, osteoarthritis, GI disorders, Alzheimer’s disease, fibromyalgia, herpes simplex, asthma, low back pain, inflammatory biomarkers, and hyperlipidemia.
The company offers medical evaluations and testing to study patients' chronic conditions.
Current Investors
Headlands Research, Inc.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.clinvest.com
Verticals
HealthTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.